PharmTech's monthly newsletter, Equipment and Processing Report, reviews the Editor's Picks for the April 2012 edition from AdvantaPure and Fitzpatrick Company.
AdvantaPure
New AdvantaTube sealer and sterile welder are preprogrammed for AdvantaFlex TPE tubing
AdvantaPure supplies thermoplastic elastomer (TPE) tubing for pharma and biopharm, single-use, fluid transfer applications such as disposable molded manifolds, tubing assemblies, peristaltic pumps, and sample retention. In response to customer requests, the company introduced the AdvantaTube sealer and the AdvantaTube sterile welder, which are preprogrammed to seal and weld the company’s AdvantaFlex TPE tubing. Settings for other types of TPE tubing are also available.
Fitzpatrick Company
Contained system for roll compaction of powders
Fitzpatrick introduced the Contained Chilsonator System (CCS1025) for roll compaction of powders that is designed to fully contain all product in its processing and receiving sections and allow use in cleanrooms. An optional product containment system can be added at the discharge. The feed system design uses a horizontal feed screw to meter material and a vertical, precompression screw to deaerate and transport material to the compaction rolls. In some applications, an optional vacuum deaeration system can be used to assist in drawing entrained air from the product, thus improving compaction efficiency.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Legal and Regulatory Perspectives on 3D Printing: Drug Compounding Applications
December 10th 2024This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property rights.